Company: BSTZ
Filing Date: 2025-04-17
Form Type: SC TO-I
Source: 0001193125-25-084387
Chunk: 0

Company: BlackRock Science & Technology Term Trust
Filing Date: 2025-04-17
Form: SC TO-I
Chunk 0
---
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 BlackRock Science and Technology Term Trust (Name of Subject Company (Issuer)) BlackRock Science and Technology Term Trust (Names of Filing Person(s) (Issuer)) Common Shares of Beneficial Interest, Par Value $0.001 per share (Title of Class of Securities) 09260K101 (CUSIP Number of Class of Securities) John M. Perlowski BlackRock Science and Technology Term Trust 50 Hudson Yards New York, New York 10001 (800) 882-0052 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Person(s)) Copies to:

| Margery K. Neale, Esq.       |     | Janey Ahn, Esq.          |
| Willkie Farr & Gallagher LLP |     | BlackRock Advisors, LLC  |
| 787 Seventh Avenue           |     | 50 Hudson Yards          |
| New York, New York 10019     |     | New York, New York 10001 |

April 17, 2025 (Date Tender Offer First Published, Sent or Given to Security Holders)

| ☐ | Check the box if the filing relates solely to preliminary communications made before the commencement of a 
 tender offer.                                                                                              |

Check the appropriate boxes below to designate any transactions to which this statement relates:

| ☐ | third-party tender offer subject to Rule 14d-1 |

| ☒ | issuer tender offer subject to Rule 13e-4 |

| ☐ | going-private transaction subject to Rule 13e-3 |

| ☐ | amendment to Schedule 13D under Rule 13d-2 |

Check the following box if the filing is a final amendment reporting the results of the tender offer. ☐

Introductory Statement This Issuer Tender Offer Statement on Schedule TO relates to an offer by BlackRock Science and Technology Term Trust, a Delaware statutory trust (the “Fund”), to repurchase 2.5% of its issued and outstanding common shares of beneficial interest, par value $0.001 per share (the “Shares”), in exchange for cash at a price equal to 98% of the net asset value (“NAV”) per Share (the “Purchase Price”) determined as of the close